Drug Profile


Alternative Names: CRx-102; CRx-102 aligned release; Prednisolone/dipyridamole; Prednisolone/dipyridamole aligned release; Synavive; Synavive AR; Z-102

Latest Information Update: 01 Aug 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CombinatoRx
  • Developer CombinatoRx; Zalicus
  • Class Anti-inflammatories; Antirheumatics; Corticosteroids; Glucocorticoids; Pregnadienetriols; Pyrimidines; Small molecules
  • Mechanism of Action Cyclic GMP phosphodiesterase inhibitors; Glucocorticoid receptor agonists; Immunosuppressants; Nucleoside transport protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Inflammation; Osteoarthritis; Periodontal disorders; Rheumatoid arthritis

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 25 Jul 2016 EPIRUS Biopharmaceuticals files for Chapter 7 bankruptcy (Epirus Biopharmaceuticals 8-K, July 2016)
  • 15 Jul 2014 Zalicus has merged with EPIRUS Biopharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top